Login to Your Account

Financings NEWS

With two more initial public offerings (IPOs) pricing Thursday – a $97.5 million home run by cystic fibrosis player Proqr Therapeutics BV and a $40.2 million infield fly by antibiotics developer Foamix Pharmaceuticals Ltd. – the ups and downs of the IPO market seemed analogous to the set-up for baseball's postseason play.

DUBLIN – Dutch venture capital firm Aglaia has secured $65 million in a first closing of a new oncology fund, which is targeting a final close of $80 million to $100 million.

HONG KONG – The world's largest health care-dedicated investment firm, Orbimed, has secured a $325 million pan-Asia fund to invest in health care markets in the region, particularly in China and India.
More Financings Headlines

Cast Your Vote

Has biotech’s bubble burst?: